Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Hutchmed China Ltd (13 HK)
Watchlist
166
Analysis
Industrials
•
Hong Kong
HUTCHMED (China) Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. HUTCHMED (China) markets its products worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Alibaba Group Holding
•
14 Dec 2022 09:38
China ADRs Delisting - Friday Could Be Judgment Day for over US$800bn Mcap of Stocks
PCAOB officials concluded their Hong Kong visit last month and PCAOB is due to announce its annual judgment on whether it had adequate access to US...
Sumeet Singh
Follow
867 Views
Share
bullish
•
KraneShares CSI China Internet ETF
•
03 Apr 2022 21:50
New CSRC "Provisions" Take a Step Towards Meeting PCAOB Requirements
CSRC has published new Provisions putting the onus of info management on companies, making it easier for the PCAOB to conduct on-site audits. It...
Travis Lundy
Follow
317 Views
Share
bullish
•
Hutchmed China Ltd
•
03 Aug 2023 08:12
•
Broker
Hutchmed (13 HK) – Eyes on the FDA Approval of Fruquintinib in Nov
HCM’s consolidated revenues from oncology/immunology increased 294% YoY to US$359mn in 1H23, mainly driven by the US$259mn income recognition
CMB International
Follow
206 Views
Share
bullish
•
Hutchmed China Ltd
•
18 May 2023 08:55
Hutchmed China Ltd (13.HK/HCM.US)- Stronger than Expected and Deserves More Attention from Investors
After effective strategic adjustments by the management, HUTCHMED has shown positive changes. In fact, its commercialization ability is...
Xinyao (Criss) Wang
Follow
314 Views
Share
bullish
•
Hutchison China MediTech Ltd
•
30 Oct 2023 10:31
Hutchmed China Ltd (13.HK/HCM.US) 23H1 - This Company Is Becoming More Attractive
We have seen over 35% share price rally after this insight was published. Obviously, the market is optimistic about the upcoming fruquintinib's FDA...
Xinyao (Criss) Wang
Follow
773 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.31.2
x